Asset Details
Do you wish to reserve the book?
Hyperoxemia as a risk factor for ventilator-associated pneumonia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hyperoxemia as a risk factor for ventilator-associated pneumonia
Do you wish to request the book?
Hyperoxemia as a risk factor for ventilator-associated pneumonia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hyperoxemia as a risk factor for ventilator-associated pneumonia
2016
Overview
Background
Consequences of hyperoxemia, such as acute lung injury, atelectasis, and reduced bacterial clearance, might promote ventilator-associated pneumonia (VAP). The aim of our study was to determine the relationship between hyperoxemia and VAP.
Methods
This retrospective observational study was performed in a 30-bed mixed ICU. All patients receiving invasive mechanical ventilation for more than 48 hours were eligible. VAP was defined using clinical, radiologic, and quantitative microbiological criteria. Hyperoxemia was defined as PaO
2
> 120 mmHg. All data, except those related to hyperoxemia, were prospectively collected. Risk factors for VAP were determined using univariate and multivariate analysis.
Results
VAP was diagnosed in 141 of the 503 enrolled patients (28 %). The incidence rate of VAP was 14.7 per 1000 ventilator days. Hyperoxemia at intensive care unit admission (67 % vs 53 %, OR = 1.8, 95 % CI (1.2, 29),
p
<0.05) and number of days spent with hyperoxemia were significantly more frequent in patients with VAP, compared with those with no VAP. Multivariate analysis identified number of days spent with hyperoxemia (OR = 1.1, 95 % CI (1.04, 1.2) per day,
p
= 0.004), simplified acute physiology score (SAPS) II (OR = 1.01, 95 % CI (1.002, 1.024) per point,
p
< 0 .05), red blood cell transfusion (OR = 1.8, 95 % CI (1.2, 2.7),
p
= 0.01), and proton pomp inhibitor use (OR = 1.9, 95 % CI (1.03, 1.2),
p
< 0.05) as independent risk factors for VAP. Other multiple regression models also identified hyperoxemia at ICU admission (OR = 1.89, 95 % CI (1.23, 2.89),
p
= 0.004), and percentage of days with hyperoxemia (OR = 2.2, 95 % CI (1.08, 4.48),
p
= 0.029) as independent risk factors for VAP.
Conclusion
Hyperoxemia is independently associated with VAP. Further studies are required to confirm our results.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
